Charlie Henry is Co-founder, CEO and Chairman of Op-T. He brings 30 years of biomedical company development and management experience to his leadership of Op-T. Mr. Henry has worked within the  diagnostic, device, and pharmaceutical sectors as a CEO. He has raised tens of millions of dollars through  equity sales, negotiated complex licensing and distribution agreements with international and domestic  partners, and led successful corporate sales to public and private acquirers.